Evidence map›Paper›PMID 38243093›Full record

ReviewNature protocols2024

Production and use of antigen tetramers to study antigen-specific B cells.

Allyssa Phelps, Diego Pazos-Castro, Francesca Urselli, Emily Grydziuszko, Olivia Mann-Delany, Allison Fang, Tina D Walker, Rangana Talpe Guruge, Jaime Tome-Amat, Araceli Diaz-Perales and 5 more

Erratum issuedOpen access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Extending ImmunoSpotVaccines · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Allyssa Phelps *Department of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-5025-7459
Diego Pazos-Castro *Department of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-0686-5131
Francesca UrselliVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-5839-7384
Emily GrydziuszkoDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Olivia Mann-DelanyDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Allison FangDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Tina D WalkerDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Rangana Talpe GurugeDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Jaime Tome-AmatCentre for Plant Biotechnology and Genomics, Universidad Politécnica de Madrid - Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria/Consejo Superior de Investigaciones Científicas (UPM-INIA/CSIC), Universidad Politécnica de Madrid, Madrid, Spain.ORCID 0000-0003-4442-3649
Araceli Diaz-PeralesCentre for Plant Biotechnology and Genomics, Universidad Politécnica de Madrid - Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria/Consejo Superior de Investigaciones Científicas (UPM-INIA/CSIC), Universidad Politécnica de Madrid, Madrid, Spain.
Susan WasermanDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Jim BoonyaratanakornkitVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Manel JordanaDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.
Justin J TaylorVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. justintaylor@virginia.edu.ORCID 0000-0001-9718-2901
Joshua F E KoenigDepartment of Medicine, Schroeder Allergy and Immunology Research Institute, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada. koenigjf@mcmaster.ca.ORCID 0000-0002-8909-5039
McMaster University Medical Centre · CAConsejo Superior de Investigaciones Científicas · ESCarter Center · USFred Hutch Cancer Center · USUniversity of Washington · US

Funding

In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticlesR01AI167009 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Jennifer Eileen Adair, Justin J Taylor · 2022 to 2026
$4.2M
Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogensR01AI158728 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Jennifer Eileen Adair, Justin J Taylor · 2022 to 2026
$3.8M
Identification and Analysis of HIV-specific Naive B cells in HIV-unexposed IndividualsR01AI122912 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAYLOR, JUSTIN J · 2016 to 2020
$2.7M
NIAID NIH HHS R01 AI122912NIAID NIH HHS R01 AI158728NIAID NIH HHS R01 AI167009U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI122912U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI158728U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI167009
6 · The paper itself

Abstract

B cells generate antibodies that provide protection from infection, but also cause pathology in autoimmune and allergic conditions. Antigen-specific B cells can be detected by binding their surface antibody receptors with native antigens conjugated to fluorescent probes, a technique that has revealed substantial insight into B cell activation and function. This protocol describes the process of generating fluorescent antigen tetramer probes and delineates a process of enriching large samples based on antigen-specificity for high-resolution analyses of the antigen-specific B cell repertoire. Enrichment of tetramer-binding cells allows for detection of antigen-specific B cells as rare as 1 in 100 million cells, providing sufficient resolution to study naive B cells and IgE-expressing cells by flow cytometry. The generation of antigen tetramers involves antigen biotinylation, assessment of biotin:antigen ratio for optimal tetramer loading and polymerization around a streptavidin-fluorophore backbone. We also describe the construction of a control tetramer to exclude B cells binding to the tetramer backbone. We provide a framework to validate whether tetramer probes are detecting true antigen-specific B cells and discuss considerations for experimental design. This protocol can be performed by researchers trained in basic biomedical/immunological research techniques, using instrumentation commonly found in most laboratories. Constructing the antigen and control tetramers takes 9 h, though their specificity should be assessed before experimentation and may take weeks to months depending on the method of validation. Sample enrichment requires ~2 h but is generally time and cost neutral as fewer cells are run through the flow cytometer.

Indexed as

AntigensB-LymphocytesFlow CytometryAntigens

Identifiers

PMID38243093
OpenAlexW4391023230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.